+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aesthetic Injectables Market by Product Type (Botulinum Toxin, Dermal Fillers), Mode of Administration (Intradermal, Intramuscular), Application, End-User - Global Forecast 2025-2030- Product Image
Aesthetic Injectables Market by Product Type (Botulinum Toxin, Dermal Fillers), Mode of Administration (Intradermal, Intramuscular), Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Aesthetic Injectables Market by Product Type (Botulinum Toxin, Dermal Fillers), Mode of Administration (Intradermal, Intramuscular), Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5790377
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The aesthetic injectables market is rapidly reshaping the landscape of cosmetic medicine, driven by evolving patient expectations, advanced formulation technologies, and dynamic consumer segments. Senior decision-makers seeking actionable strategies will find this report an essential resource for capturing market shifts and aligning growth plans with current realities.

Market Snapshot: Aesthetic Injectables Market Growth and Trends

The Aesthetic Injectables Market grew from USD 12.67 billion in 2024 to USD 13.97 billion in 2025. It is expected to continue growing at a CAGR of 10.69%, reaching USD 23.31 billion by 2030. This trajectory reflects mainstream adoption across diverse demographics, supported by both product innovation and a shift toward minimally invasive procedures. Expansion is notable across both established and emerging markets, as providers prioritize patient-centric solutions and agile delivery models.

Scope & Segmentation: Key Dimensions Shaping Market Opportunity

This report presents a comprehensive segmentation and analysis to illuminate where the greatest opportunities and challenges exist within the aesthetic injectables sector.

  • Product Types: Botulinum toxin (Type A and Type B), dermal fillers (including calcium hydroxylapatite, collagen, hyaluronic acid, polyalkylimide, polylactic acid, and polymethyl-methacrylate microspheres)
  • Mode of Administration: Intradermal and intramuscular injection methods
  • Application Areas: Acne scar treatment, chin & jaw restructuring, facial line correction (crows feet, forehead, glabellar, marionette lines), and lips augmentation
  • End User Settings: Dermatology clinics, medical spas and beauty centers, and plastic surgery centers
  • Regional Coverage: Americas (including the United States, Canada, Mexico, Brazil, Argentina, with state-level detail for major US states), Europe, Middle East & Africa (covering key Western European, Middle Eastern, and African markets), Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asia, and others)
  • Key Companies Assessed: AbbVie Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Teoxane SA, Croma-Pharma GmbH, Revance Therapeutics, Inc., and additional leading manufacturers active globally

Aesthetic Injectables Market: Key Takeaways for Decision-Makers

  • Innovations in facial mapping and formulation chemistry are enabling more precise and longer-lasting aesthetic outcomes, prompting clinics to update protocols and invest in clinician training.
  • Consumer demand is diversifying, with younger adults and male patients increasingly viewing injectables as preventative treatments rather than solely corrective, expanding the overall user base.
  • Strategic alliances between injectable practices and digital health providers streamline patient engagement, with telemedicine enhancing care access and ongoing support past procedure visits.
  • Market democratization is making treatments more accessible through tiered service offerings and flexible payment models, which in turn is accelerating adoption across new geographic and demographic segments.
  • Continuous collaboration between manufacturers, clinicians, and regulators sustains momentum for innovation, while ensuring strict quality and safety standards remain in place.

Tariff Impact: Market Adaptation and Supply Chain Strategy

Recent US tariff changes have required manufacturers to reassess sourcing and production strategies. In response to higher costs on imported raw materials, leading firms are increasing local manufacturing, forging stronger ties with regional contract manufacturers, and reevaluating pricing models. Promotions, bundled service packages, and loyalty programs are helping clinics offset the impact for patients, maintaining competitive differentiation while safeguarding quality and compliance.

Methodology & Data Sources

This research integrates extensive primary insights—drawn from interviews and surveys with clinicians, manufacturers, and regulatory experts—with robust secondary data from scientific literature, regulatory archives, and industry disclosures. Consistency is ensured through triangulation and rigorous benchmarking practices.

Why This Report Matters: Strategic Value for Leaders

  • Equip leadership teams with actionable intelligence on product innovation, patient trends, and regional growth avenues to inform strategic decisions.
  • Enable effective risk management by clarifying supply chain vulnerabilities and regulatory considerations, especially in the context of evolving trade dynamics.

Conclusion

The aesthetic injectables market is evolving through technological progress and regulatory adjustment, redefining growth opportunities and care delivery models. Decision-makers ready to leverage these insights will be well-positioned to navigate complexity and realize sustained competitive strength.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of microdosing in botulinum toxin treatments to achieve subtle aesthetic enhancements
5.2. Development of plant-derived collagen stimulators as bioidentical alternatives to synthetic dermal fillers
5.3. Integration of AI-driven facial analysis platforms to personalize injectable treatment planning and improve outcomes
5.4. Expansion of male-focused aesthetic injectable services driven by rising consumer openness and social media influence
5.5. Advancement in long-lasting hyaluronic acid formulations reducing retreatment frequency for patients seeking convenience
5.6. Adoption of virtual consultation and remote follow-up technologies to streamline patient journey post injectable procedures
5.7. Introduction of combination therapy protocols using botulinum toxin and microcannula techniques to minimize downtime
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Aesthetic Injectables Market, by Product Type
8.1. Introduction
8.2. Botulinum Toxin
8.2.1. Botulinum Toxin Type A
8.2.2. Botulinum Toxin Type B
8.3. Dermal Fillers
8.3.1. Calcium Hydroxylapatite
8.3.2. Collagen
8.3.3. Hyaluronic Acid
8.3.4. Polyalkylimide
8.3.5. Polylactic Acid
8.3.6. Polymethyl-Methacrylate Microspheres
9. Aesthetic Injectables Market, by Mode of Administration
9.1. Introduction
9.2. Intradermal
9.3. Intramuscular
10. Aesthetic Injectables Market, by Application
10.1. Introduction
10.2. Acne Scar Treatment
10.3. Chin & Jaw Restructuring
10.4. Facial Line Correction
10.4.1. Crows Feet Lines
10.4.2. Forehead Lines
10.4.3. Glabellar Lines
10.4.4. Marionette Lines
10.5. Lips Augmentation
11. Aesthetic Injectables Market, by End-User
11.1. Introduction
11.2. Dermatology Clinics
11.3. Medical Spas & Beauty Centers
11.4. Plastic Surgery Centers
12. Americas Aesthetic Injectables Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Aesthetic Injectables Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Aesthetic Injectables Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AbbVie Inc.
15.3.2. Across Co., Ltd.
15.3.3. Adoderm GmbH
15.3.4. Ajinomoto Bio-Pharma Services
15.3.5. Anika Therapeutics, Inc.
15.3.6. Bio Plus Co., Ltd.
15.3.7. Bioxis Pharmaceuticals
15.3.8. Bloomage BioTechnology Corporation Limited
15.3.9. Bohus Biotech AB
15.3.10. Caregen Co., Ltd.
15.3.11. Croma-Pharma GmbH
15.3.12. Cutera, Inc.
15.3.13. Cynosure, LLC
15.3.14. Daewoong Pharmaceuticals Co.Ltd
15.3.15. Dr. Korman Laboratories Ltd.
15.3.16. Eisai Co., Ltd
15.3.17. Galderma SA
15.3.18. Gufic Biosciences Ltd.
15.3.19. HUGEL, Inc.
15.3.20. Hugh Source International Ltd.
15.3.21. HyunDae Meditech Co., Ltd.
15.3.22. Ipsen Pharma SAS
15.3.23. Laboratoires Vivacy, S.A.S.
15.3.24. Medytox Co., Ltd
15.3.25. Merz Pharma GmbH & Co.KGaA
15.3.26. PharmaResearch Co. Ltd
15.3.27. Prollenium Medical Technologies Inc.
15.3.28. Q-Med Aktiebolag
15.3.29. Revance Therapeutics, Inc.
15.3.30. S.K. Bio Partners. Inc.
15.3.31. SciVision Biotech Inc.
15.3.32. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
15.3.33. Shanghai Haohai Biological Technology Co., Ltd.
15.3.34. Sinclair Pharma Ltd
15.3.35. SNJ Co., Ltd.
15.3.36. Suneva Medical, Inc.
15.3.37. Taj Pharmaceuticals
15.3.38. Teoxane SA
15.3.39. USWM, LLC
15.3.40. Zimmer Biomet Holdings, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. AESTHETIC INJECTABLES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AESTHETIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. AESTHETIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. AESTHETIC INJECTABLES MARKET: RESEARCHAI
FIGURE 24. AESTHETIC INJECTABLES MARKET: RESEARCHSTATISTICS
FIGURE 25. AESTHETIC INJECTABLES MARKET: RESEARCHCONTACTS
FIGURE 26. AESTHETIC INJECTABLES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AESTHETIC INJECTABLES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN TYPE A, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN TYPE A, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN TYPE B, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN TYPE B, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY CALCIUM HYDROXYLAPATITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY CALCIUM HYDROXYLAPATITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COLLAGEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY POLYALKYLIMIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY POLYALKYLIMIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY POLYMETHYL-METHACRYLATE MICROSPHERES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY POLYMETHYL-METHACRYLATE MICROSPHERES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY INTRADERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY ACNE SCAR TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY ACNE SCAR TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY CHIN & JAW RESTRUCTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY CHIN & JAW RESTRUCTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY CROWS FEET LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY CROWS FEET LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FOREHEAD LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FOREHEAD LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY GLABELLAR LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY GLABELLAR LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MARIONETTE LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MARIONETTE LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY LIPS AUGMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY LIPS AUGMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MEDICAL SPAS & BEAUTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MEDICAL SPAS & BEAUTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PLASTIC SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PLASTIC SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 104. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 105. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 106. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 107. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 112. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 113. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 115. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 118. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 119. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 126. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 127. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 187. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 190. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 191. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 192. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 193. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 198. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 199. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 200. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 201. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 204. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 205. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 206. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 207. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 212. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 213. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 214. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 229. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 232. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 233. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 234. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 235. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 240. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 241. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 242. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 243. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 246. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 247. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 248. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 249. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 254. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 255. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 256. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 299. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 302. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 303. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 304. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 305. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 310. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2025-2030 (USD MILLION)
TABLE 311. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 312. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS AESTHETIC INJECTABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Aesthetic Injectables market report include:
  • AbbVie Inc.
  • Across Co., Ltd.
  • Adoderm GmbH
  • Ajinomoto Bio-Pharma Services
  • Anika Therapeutics, Inc.
  • Bio Plus Co., Ltd.
  • Bioxis Pharmaceuticals
  • Bloomage BioTechnology Corporation Limited
  • Bohus Biotech AB
  • Caregen Co., Ltd.
  • Croma-Pharma GmbH
  • Cutera, Inc.
  • Cynosure, LLC
  • Daewoong Pharmaceuticals Co.Ltd
  • Dr. Korman Laboratories Ltd.
  • Eisai Co., Ltd
  • Galderma SA
  • Gufic Biosciences Ltd.
  • HUGEL, Inc.
  • Hugh Source International Ltd.
  • HyunDae Meditech Co., Ltd.
  • Ipsen Pharma SAS
  • Laboratoires Vivacy, S.A.S.
  • Medytox Co., Ltd
  • Merz Pharma GmbH & Co.KGaA
  • PharmaResearch Co. Ltd
  • Prollenium Medical Technologies Inc.
  • Q-Med Aktiebolag
  • Revance Therapeutics, Inc.
  • S.K. Bio Partners. Inc.
  • SciVision Biotech Inc.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  • Shanghai Haohai Biological Technology Co., Ltd.
  • Sinclair Pharma Ltd
  • SNJ Co., Ltd.
  • Suneva Medical, Inc.
  • Taj Pharmaceuticals
  • Teoxane SA
  • USWM, LLC
  • Zimmer Biomet Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 13.97 Billion
Forecasted Market Value ( USD ) by 2030 $ 23.31 Billion
Compound Annual Growth Rate10.6%
Regions CoveredGlobal
No. of Companies Mentioned41

Related Topics

Related Reports

Facial Injectables Market by Product Type (Botulinum Toxin, Dermal Fillers), Treatment Area (Cheeks Augmentation, Crow'S Feet, Forehead Lines), End User, Application Method, Age Group - Global Forecast 2025-2030 - Product Image

Facial Injectables Market by Product Type (Botulinum Toxin, Dermal Fillers), Treatment Area (Cheeks Augmentation, Crow'S Feet, Forehead Lines), End User, Application Method, Age Group - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Injectable Botulinum Toxin for Aesthetic Medicine Market by Product Type (AbobotulinumtoxinA, Botulinum Toxin Type B, IncobotulinumtoxinA), Treatment Indication (Lower Face, Upper Face), End User, Distribution Channel, Formulation, Age Group, Gender - Global Forecast 2025-2030 - Product Image

Injectable Botulinum Toxin for Aesthetic Medicine Market by Product Type (AbobotulinumtoxinA, Botulinum Toxin Type B, IncobotulinumtoxinA), Treatment Indication (Lower Face, Upper Face), End User, Distribution Channel, Formulation, Age Group, Gender - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Aesthetic Injectables - Global Strategic Business Report - Product Image

Aesthetic Injectables - Global Strategic Business Report

  • Report
  • 212 Pages
  • Global
From
Aesthetic Injectable Devices Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product, Dermal Fillers, Device Type, Application, Age Group, Gender, End User, and Geography - Product Image

Aesthetic Injectable Devices Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product, Dermal Fillers, Device Type, Application, Age Group, Gender, End User, and Geography

  • Report
  • 363 Pages
  • Global
From
Facial Injectable Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Facial Injectable Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From

About the Aesthetic Injectable Market

The Aesthetic Injectable market is a subset of the Infusions and Injectables market, which includes a variety of treatments and products used to improve the appearance of the skin. Aesthetic Injectables are minimally invasive treatments that use a variety of substances, such as hyaluronic acid, botulinum toxin, and poly-L-lactic acid, to reduce wrinkles, enhance facial contours, and improve skin texture. These treatments are typically administered by a qualified healthcare professional, such as a dermatologist or plastic surgeon. Aesthetic Injectables are becoming increasingly popular due to their convenience, affordability, and minimal downtime. They are also considered to be a safe and effective way to improve the appearance of the skin. Some companies in the Aesthetic Injectable market include Allergan, Galderma, Merz, and Revance. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.